Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran). (Q50225868)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran). |
scientific article published in April 2002 |
Statements
Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran) (English)
Mattsson C
Björkman JA
Abrahamsson T
Nerme V
Schatteman K
Leurs J
Scharpé S